C.‐Y. Park

Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse‐controlled release for obesity

Jun Goo Kang, C.‐Y. Park, Jae‐Heon Kang et al. · Diabetes Obesity and Metabolism · 2010 · 119 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase <scp>III</scp> clinical trial with a 28‐week extension

Sang‐Man Jin, C.‐Y. Park, Y. M. Cho et al. · Diabetes Obesity and Metabolism · 2015 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Higher Serum Free Thyroxine Levels Are Associated with Coronary Artery Disease

Chan‐Hee Jung, Eun‐Jung Rhee, Hun-Sub Shin et al. · Endocrine Journal · 2008 · 36 citations · Full text

Medicine, Cardiology, Endocrinology +15

Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase‐4 inhibitor, in <scp>K</scp> orean patients with type 2 diabetes mellitus: a 24‐week multicentre, randomized, double‐blind, placebo‐controlled phase <scp>III</scp> trial

Sangmo Hong, C.‐Y. Park, Kyung Ah Han et al. · Diabetes Obesity and Metabolism · 2016 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Atherogenic dyslipidaemic profiles associated with the development of Type 2 diabetes: a 3.1‐year longitudinal study

You‐Cheol Hwang, Hee-Chul Ahn, Seung Hun Yu et al. · Diabetic Medicine · 2013 · 22 citations

Medicine, Endocrinology, Diabetology +6